99.8% accuracy
01 · Analysis
Neural Data Mapping
Automatically categorize and link complex neurobiological data points with 99.8% accuracy using our LLM-driven parser.
Now in Private Alpha
Genivra.
CNS Trials, Decoded by AI.
Analyze CNS clinical trials before they fail. Built for biotech investors, BD teams, and CNS research groups evaluating neurodegenerative pipelines.
Research Supported By
UC Berkeley
Stanford
HarvardAlzheimer'sParkinson'sALSDepressionSchizophreniaMultiple SclerosisHuntington'sEpilepsyBipolarPTSDMigraineStrokeAlzheimer'sParkinson'sALSDepressionSchizophreniaMultiple SclerosisHuntington'sEpilepsyBipolarPTSDMigraineStroke
Featured — Capabilities
Built for the future of clinical intelligence.
Genivra models Phase II transition risk using imaging and biomarker validation signals across neurodegenerative programs.
73%
02 · Prediction
Predictive Outcomes
Simulate trial results based on historical cohorts to identify potential bottlenecks before they impact your timeline.
Audit trail0%
03 · Compliance
Immutable Compliance
Enterprise-grade security with audit trails logged on a private ledger, ensuring absolute data integrity and regulatory readiness.
04 · Reporting
Automated Reporting
Generate publication-ready reports and visualization suites with a single click, formatted for FDA and EMA submissions.
Built for
the future of clinical intelligence.
Genivra models Phase II transition risk using imaging and biomarker validation signals across neurodegenerative programs.
Trials Managed
450+
Faster Processing
40%
Data Points
12M+
Retention Rate
99%
Biomarker ValidationImaging SignalsPhase II TransitionPatient EnrichmentRegulatory ReadinessProtocol OptimizationBiomarker ValidationImaging SignalsPhase II TransitionPatient EnrichmentRegulatory ReadinessProtocol OptimizationBiomarker ValidationImaging SignalsPhase II TransitionPatient EnrichmentRegulatory ReadinessProtocol Optimization
Get Started
Ready to accelerate your research?
Join leading biotech teams who trust Genivra for their critical intelligence needs.